Junmin Chen

1.6k total citations · 1 hit paper
50 papers, 1.0k citations indexed

About

Junmin Chen is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Junmin Chen has authored 50 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 19 papers in Hematology and 12 papers in Oncology. Recurrent topics in Junmin Chen's work include Multiple Myeloma Research and Treatments (14 papers), Protein Degradation and Inhibitors (6 papers) and Spondyloarthritis Studies and Treatments (4 papers). Junmin Chen is often cited by papers focused on Multiple Myeloma Research and Treatments (14 papers), Protein Degradation and Inhibitors (6 papers) and Spondyloarthritis Studies and Treatments (4 papers). Junmin Chen collaborates with scholars based in China, Australia and Canada. Junmin Chen's co-authors include Wenzhong Que, Zhiyong Zeng, Haoran Zhang, Chao Liu, Kunshen Liu, Yanqiu Gao, Shuo Wang, Xiaohong Chen, Xiaoying Jiang and Rongfang Hu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cochrane Database of Systematic Reviews and American Journal of Roentgenology.

In The Last Decade

Junmin Chen

48 papers receiving 996 citations

Hit Papers

Peroxisome proliferator-activated receptor gamma coactiva... 2024 2026 2025 2024 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junmin Chen China 16 233 183 174 139 133 50 1.0k
Kenneth G. Proctor United States 25 191 0.8× 124 0.7× 433 2.5× 568 4.1× 201 1.5× 98 1.6k
Marc van der Planken Belgium 22 128 0.5× 516 2.8× 256 1.5× 25 0.2× 123 0.9× 50 1.3k
Lucas G. Fernández United States 17 197 0.8× 27 0.1× 369 2.1× 63 0.5× 280 2.1× 25 954
Ronald L. Gross United States 25 435 1.9× 43 0.2× 210 1.2× 107 0.8× 98 0.7× 87 2.0k
Martina Broecker‐Preuss Germany 24 321 1.4× 121 0.7× 188 1.1× 12 0.1× 66 0.5× 51 1.4k
Nicole Hergovich Austria 12 49 0.2× 383 2.1× 116 0.7× 23 0.2× 70 0.5× 14 979
Takuji Tomimatsu Japan 24 144 0.6× 102 0.6× 157 0.9× 78 0.6× 213 1.6× 126 1.8k
Oscar McCook Germany 20 224 1.0× 46 0.3× 116 0.7× 120 0.9× 168 1.3× 64 1.0k
Leslie Ritter United States 18 155 0.7× 49 0.3× 89 0.5× 21 0.2× 69 0.5× 40 855
Lars L. Thomsen Denmark 21 88 0.4× 621 3.4× 74 0.4× 26 0.2× 127 1.0× 35 1.5k

Countries citing papers authored by Junmin Chen

Since Specialization
Citations

This map shows the geographic impact of Junmin Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junmin Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junmin Chen more than expected).

Fields of papers citing papers by Junmin Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junmin Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junmin Chen. The network helps show where Junmin Chen may publish in the future.

Co-authorship network of co-authors of Junmin Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Junmin Chen. A scholar is included among the top collaborators of Junmin Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junmin Chen. Junmin Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Zhenying, et al.. (2025). 68Ga-Pentixafor PET in Combination With MRI Improves the Differential Diagnosis of Glioblastoma and Primary Central Nervous System Lymphoma. Clinical Nuclear Medicine. 50(4). 324–331. 1 indexed citations
2.
Chen, Junmin, et al.. (2024). Role of BACH1 in multiple myeloma. Hematology. 29(1). 2352687–2352687. 2 indexed citations
3.
Wu, Xue, Zhe Zhang, Xiaopeng Wu, et al.. (2024). TNIK in disease: from molecular insights to therapeutic prospects. APOPTOSIS. 29(9-10). 1361–1376. 2 indexed citations
4.
Li, Tingting, Pingping Xiao, Jun‐Fang Lin, et al.. (2024). NCX1/Ca2+ promotes autophagy and decreases bortezomib activity in multiple myeloma through non-canonical NFκB signaling pathway. Cell Communication and Signaling. 22(1). 258–258. 4 indexed citations
5.
Xiao, Pingping, et al.. (2024). SSBP1 is a novel prognostic marker and promotes disease progression via p38MAPK signaling pathway in multiple myeloma. Molecular Carcinogenesis. 63(4). 728–741. 1 indexed citations
6.
Wu, Xue, Zheng Wang, Zibin Liang, et al.. (2024). Pleiotropic role of CCR9/CCL25 signaling in adriamycin-induced cardiomyopathy. Journal of Advanced Research. 75. 707–722. 1 indexed citations
7.
Li, Tingting, et al.. (2022). NCX1 disturbs calcium homeostasis and promotes RANKL-induced osteoclast differentiation by regulating JNK/c-Fos/NFATc1 signaling pathway in multiple myeloma. Clinical and Experimental Medicine. 23(5). 1581–1596. 2 indexed citations
8.
Zeng, Zhiyong, et al.. (2021). Single cell RNA-seq data and bulk gene profiles reveal a novel signature of disease progression in multiple myeloma. Cancer Cell International. 21(1). 511–511. 7 indexed citations
9.
Chen, Junmin, et al.. (2021). Risk factors for the flare of systemic lupus erythematosus and its influence on prognosis: a single-center retrospective analysis. Advances in Rheumatology. 61(1). 43–43. 7 indexed citations
10.
Deng, Yujie, Xiaohui Chen, Chuanzhong Huang, et al.. (2019). EZH2/Bcl-2 Coexpression Predicts Worse Survival in Diffuse Large B-cell Lymphomas and Demonstrates Poor Efficacy to Rituximab in Localized Lesions. Journal of Cancer. 10(9). 2006–2017. 15 indexed citations
11.
Lin, Jinpiao, Yujue He, Junmin Chen, et al.. (2016). A critical role of transcription factor YY1 in rheumatoid arthritis by regulation of interleukin-6. Journal of Autoimmunity. 77. 67–75. 50 indexed citations
12.
Chen, Junmin, et al.. (2016). Serum levels of brain-derived neurotrophic factor are associated with depressive symptoms in patients with systemic lupus erythematosus. Psychoneuroendocrinology. 78. 246–252. 16 indexed citations
13.
Lin, Jinpiao, Yujue He, Junmin Chen, et al.. (2016). Datasets of YY1 expression in rheumatoid arthritis patients. Data in Brief. 9. 1034–1038. 4 indexed citations
14.
Deng, Yujie, et al.. (2016). [Expression and Prognostic Significance of H3K27 Trimethylation Protein in DLBCL].. PubMed. 24(5). 1379–1385. 2 indexed citations
15.
Zeng, Zhiyong, Junfang Lin, & Junmin Chen. (2013). Bortezomib for patients with previously untreated multiple myeloma: a systematic review and meta-analysis of randomized controlled trials. Annals of Hematology. 92(7). 935–943. 21 indexed citations
16.
Que, Wenzhong, et al.. (2013). NS-398 enhances the efficacy of bortezomib against RPMI8226 human multiple myeloma cells. Molecular Medicine Reports. 7(5). 1641–1645. 7 indexed citations
17.
Chen, Junmin. (2012). Construction and Identification of Eukaryotic Expression Vector Expressing Human DC-STAMP. 1 indexed citations
18.
Chen, Junmin. (2011). Gateway technical supported construction of a recombinant adenovirus vector pAd-NK4. Zhongguo yaolixue tongbao. 2 indexed citations
19.
Zhang, Haoran, Junmin Chen, & Wenzhong Que. (2011). Allogeneic peripheral blood stem cell and bone marrow transplantation for hematologic malignancies: Meta-analysis of randomized controlled trials. Leukemia Research. 36(4). 431–437. 24 indexed citations
20.
Zeng, Zhiyong, et al.. (2010). IgM multiple myeloma presenting with bleeding tendency: a case report with immunophenotype analysis. Oncology Letters. 2(1). 55–57.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026